Harmes-Agent deploys a coordinated multi-agent AI system to detect adverse drug reactions, identify dangerous interactions, and protect patients in real-time across clinical settings.
Six specialized AI agents working in concert to ensure medication safety at every stage of patient care.
Real-time monitoring of patient data streams to detect early signals of adverse drug reactions before they become critical.
Multi-dimensional interaction analysis covering pharmacokinetic, pharmacodynamic, and genetic factors for comprehensive safety checks.
Incorporates genetic profiling data to predict individual patient responses and personalize medication safety recommendations.
Specialized agents for detection, analysis, alerting, and reporting work together seamlessly through an orchestrated communication protocol.
Dynamic risk quantification using Bayesian inference to assign severity scores and prioritize clinical interventions effectively.
Automated generation of safety reports compliant with FDA MedWatch, EMA EudraVigilance, and WHO VigiBase standards.
Powered by state-of-the-art language models and medical knowledge graphs for reliable clinical decision support.
From hospital wards to community pharmacies, Harmes-Agent adapts to diverse clinical environments.
Continuous surveillance of medication orders across all inpatient units, catching polypharmacy risks and duplicate therapies in real-time before dispensing.
Automated adverse event detection and reporting for clinical research, ensuring participant safety while streamlining pharmacovigilance workflows.
Extended monitoring of patients after hospital discharge, integrating patient-reported outcomes with wearable data to catch delayed adverse reactions.
Scalable pricing that grows with your organization's medication safety needs.
Join healthcare organizations worldwide using Harmes-Agent to prevent adverse drug reactions and protect patient safety.